NCPA: Gallup Poll Finds Public Confidence in Pharmacists at Record High

Published Online: Monday, December 3, 2012
Follow Pharmacy_Times:
PRESS RELEASE

ALEXANDRIA, Va. (Dec. 3, 2012) – National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA, issued the following statement in response to the annual Gallup survey regarding professional honesty and ethics:

“Congratulations to America’s pharmacists for setting a record high in trustworthiness in Gallup’s annual survey for 2012. An impressive 75% of respondents categorized pharmacists very high or high by the honesty and ethics standard. Since the audience is the American people, this ranking is a testimony to the good will generated by the patient-friendly approach of pharmacists who are accessible, responsive and take tremendous pride helping patients achieve the best health outcomes at the lowest costs.

“In the Gallup’s more than three-decade-old survey the level of respect for pharmacists has been consistently high. We don’t rest on our laurels; instead each year we strive to become better. Our hope is that the decision makers in the private and public sector who make policy and choose prescription drug plans will tap further into the expertise and results pharmacists can bring to health care. For example, the trust that Americans place in their pharmacists makes these highly trained health care professionals a prime resource to help improve outcomes and reduce costs by boosting patient compliance with their prescribed medication regimen.”

Related Articles
The National Community Pharmacists Association today praised a Medicare final regulation to discourage Medicare Part D prescription drug plans from paying long-term care pharmacies lower, prorated dispensing fees for "short-cycle" prescriptions.
Seniors would have more convenient access to discounted or "preferred" copays for prescription drugs at their pharmacy of choice under new bipartisan legislation introduced recently and endorsed today by the National Community Pharmacists Association.
The Corrective Action Plan that federal Medicare officials have requested of Aetna is an important first step and the Centers for Medicare & Medicaid Services should go one further by issuing new guidance to all Medicare Part D prescription drug plan sponsors to prevent a 2016 repeat of the Aetna problems experienced in early 2015.
Beneficiaries, CMS, Taxpayers would benefit from uniform approach.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$